Generic drug of the therapeutic class: Dermatology
active ingredients: Ethanol
laboratory: Gifrer and Barbezat
Solution for cutaneous application
Bottle of 500 ml
· Antisepsis of small and superficial wounds.
· Preparation of the skin before injection or puncture.
Note: Antiseptic agents are not sterilizing: they temporarily reduce the number of microorganisms.
Dosage MODIFIED ALCOHOL GIFRER 70 ° Solution for cutaneous application 500 ml bottle
Apply to the surface to be treated with a compress.
Discard the compress after use.
· Any history of hypersensitivity to any of the components, including tartrazine (or group sensitization).
· Do not use in infants under 30 months (presence of camphor).
Side effects Alcohol Alter Gifrer
Tartrazine is likely to cause sensitization.
The reactions are crossed between tartrazine and aspirin.
Risk of allergic reactions, especially cutaneous.
Reporting of suspected adverse reactions
The reporting of suspected adverse reactions after authorization of the drug is important. It allows continuous monitoring of the benefit / risk ratio of the drug. Health professionals must report any suspected adverse reactions via the national reporting system: National Agency for the Safety of Medicines and Health Products (Ansm) and the network of Regional Pharmacovigilance Centers. Website: www.ansm.sante.fr.